Safety and Efficacy of AST-120 in Patients With Non-Constipating Irritable Bowel Syndrome
Status:
Completed
Trial end date:
2010-06-01
Target enrollment:
Participant gender:
Summary
The objective of this study is to evaluate the safety and effectiveness of the experimental
drug AST-120 in treating patients with non-constipating IBS. The study will test whether or
not patients receiving AST-120 experience at least a 50% reduction in the number of days with
abdominal pain compared to placebo.